Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 243.00
-2.80 (-1.14%)
Sep 24, 2026, 5:29 PM CET
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 66.19 billion as of September 24, 2026. Its market cap has increased by 13.34% in one year.
Market Cap
66.19B
Enterprise Value
75.29B
Revenue
34.24B
Ranking
n/a
PE Ratio
24.73
Stock Price
243.00
ChartMarket Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 66.19B, an increase of 334.97%. That is a compound annual growth rate of 4.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 66.19B | 11.06% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 54.06B |
| Elekta AB | 20.79B |
| Nolato AB | 14.52B |
| Vitrolife AB | 12.57B |
| MedCap AB | 8.07B |
| Xvivo Perfusion AB | 7.56B |
| CellaVision AB | 3.97B |
| BICO Group AB | 1.58B |